Patents by Inventor Ivan FORMENTINI

Ivan FORMENTINI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
    Publication number: 20240075109
    Abstract: The invention provides compositions and methods useful for the treatment and prevention of conditions associated with short telomere length.
    Type: Application
    Filed: September 7, 2023
    Publication date: March 7, 2024
    Inventors: Maria Bobadilla, Ivan Formentini, Maria Antonia Blasco Marhuenda, Christian Baer, Fatima Bosch Tubert
  • Telomerase reverse transcriptase-based therapies
    Patent number: 11529396
    Abstract: The invention provides compositions and methods useful for the treatment and prevention of conditions associated with short telomere length.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: December 20, 2022
    Assignees: FUNDACIÓN DEL SECTOR PÚBLICO ESTATAL CENTRO NACIONAL DL'INVESTIGACIONES ONCOLÓGICAS CARLOS III (F.S.P. CNIO), UNIVERSITAT AUTÓNOMA DE BARCELONA
    Inventors: Maria Bobadilla, Ivan Formentini, Maria Antonia Blasco Marhuenda, Christian Baer, Fàtima Bosch I Tubert
  • Telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarction
    Patent number: 11261434
    Abstract: The invention provides compositions and methods useful for the treatment and prevention of conditions associated with myocardial infarction.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: March 1, 2022
    Assignees: Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO), Universität Autónoma de Barcelona
    Inventors: Maria Antonia Blasco Marhuenda, Bruno Bernardes De Jesus, Christian Baer, Rosa María Serrano Ruiz, Fàtima Bosch I Tubert, Eduard Ayuso, Ivan Formentini, Maria Bobadilla, Jacques Mizrahi
  • TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
    Publication number: 20210260169
    Abstract: The invention provides compositions and methods useful for the treatment and prevention of conditions associated with short telomere length.
    Type: Application
    Filed: March 2, 2021
    Publication date: August 26, 2021
    Applicants: Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S., Universitat Autònoma de Barcelona
    Inventors: Maria Bobadilla, Ivan Formentini, Maria Antonia Blasco Marhuenda, Christian Baer, Fàtima Bosch Tubert
  • Biomarkers and methods for progression prediction for chronic kidney disease
    Patent number: 10274502
    Abstract: Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumin-to-creatinine ratio.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: April 30, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Maria Bobadilla, Laura Badi, Guillemette Duchateau-Nguyen, Laurent Essioux, Hanno Langen, Maria Chiara Magnone, Thomas Schindler, Martina Thier, Ivan Formentini, Gonzalo Christian Duran Pacheco, Corinne Solier, Matthias Kretzler, Viji Nair, Ju Wenju
  • TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
    Publication number: 20170232075
    Abstract: The invention provides compositions and methods useful for the treatment and prevention of conditions associated with short telomere length.
    Type: Application
    Filed: August 4, 2015
    Publication date: August 17, 2017
    Inventors: Maria BOBADILLA, Ivan FORMENTINI, Maria Antonia BLASCO MARHUENDA, Christian BAER, Fàtima BOSCH I TUBERT
  • TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH MYOCARDIAL INFARCTION
    Publication number: 20170191045
    Abstract: The invention provides compositions and methods useful for the treatment and prevention of conditions associated with myocardial infarction.
    Type: Application
    Filed: August 4, 2015
    Publication date: July 6, 2017
    Inventors: Maria Antonia BLASCO MARHUENDA, Bruno BERNARDES DE JESUS, Christian BAER, Rosa María SERRANO RUIZ, Fàtima BOSCH I TUBERT, Eduard AYUSO, Ivan FORMENTINI, Maria BOBADILLA, Jacques MIZRAHI
  • BIOMARKERS AND METHODS FOR PROGRESSION PREDICTION FOR CHRONIC KIDNEY DISEASE
    Publication number: 20160320410
    Abstract: Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumin-to-creatinine ratio.
    Type: Application
    Filed: October 31, 2014
    Publication date: November 3, 2016
    Inventors: Maria BOBADILLA, Laura BADI, Guillemette DUCHATEAU-NGUYEN, Laurent ESSIOUX, Hanno LANGEN, Maria Chiara MAGNONE, Thomas SCHINDLER, Martina THIER, Ivan FORMENTINI, Gonzalo Christian DURAN PACHECO, Corinne SOLIER, Matthias KRETZLER, Viji NAIR, JU Wenju